Rare Disease Genetic Testing Market PPT
                                 
                       
 
                   
 
 
               Rare Disease Genetic Testing Market    
 
  
 
 
• Rare Disease Genetic Testing Market Size Worth USD 3,790.38 Million by 2034 | 
CAGR: 13.2%
“Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis 
Report: By Technology, Speciality (Molecular Genetic Tests, Chromosomal Genetic 
Tests, and Biochemical Genetic Tests), Disease Type, End Use, and Region (North 
America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market 
Forecast, 2025–2034”

                        
    
 
             Rare Disease Genetic Testing Market     
  
 
• The global rare disease genetic testing market size was valued at USD 1,106.88 
million in 2024 and is expected to reach USD 1,242.80 million by 2025 and 
3,790.38 million by 2034, exhibiting a CAGR of 13.2% during 2025–2034.
Request To Sample :
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-tes
ting-market/request-for-sample
•.
           Rare Disease Genetic Testing Market     
• List of Key Companies in Rare Disease Genetic Testing Market
• 3billion, Inc.
• Ambry Genetics
• Baylor Genetics
• Blueprint Genetics (Quest Diagnostics)
• Centogene N.V.
• Eurofins Scientific
• GeneDx, LLC
• Genomenon
• Invitae Corporation
• Revvity
          Rare Disease Genetic Testing Market     
  
• Rare Disease Genetic Testing Market Report Highlights
• In terms of technology, the PCR-based testing segment is expected to grow at the fastest rate during the 
forecast period, driven by its high sensitivity, rapid turnaround time, and increasing applications in 
diagnosing rare genetic disorders.
• Based on end use, the diagnostic laboratories segment held the largest rare disease genetic testing market 
share due to the increasing demand for specialized genetic testing services, advanced diagnostic 
capabilities, and the growing adoption of next-generation sequencing (NGS) and PCR-based tests.
• In 2024, North America accounted for the largest share of the rare disease genetic testing market revenue, 
driven by the increasing prevalence of genetic disorders, rising adoption of advanced diagnostic 
technologies, and strong presence of key market players.
Buy Now :
https://www.polarismarketresearch.com/buy/549/2
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give 
unmatched nature of offering to our customers present all around the globe across industry 
verticals. Polaris Market Research has expertise in giving deep-dive market insight along with 
market intelligence to our customers spread crosswise over various undertakings. We at Polaris 
are obliged to serve our different client base present over the enterprises of medicinal services, 
healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and 
aerospace & defense, among different ventures present globally.
𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗜𝗻𝗳𝗼:
Polaris Market Research
Phone: +1-929-297-9727
Email: [email protected]